<DOC>
	<DOCNO>NCT03042390</DOCNO>
	<brief_summary>This retrospective observational study patient take regimen contain DRV / c least 24 week prior study initiation</brief_summary>
	<brief_title>Study Effectiveness Safety Darunavir/Cobicistat ( DRV/c ) Containing Regimens Routine Clinical Practice</brief_title>
	<detailed_description>The study include 750 patient record data 24 week . The study also record data 48 week patient data available</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Cobicistat</mesh_term>
	<mesh_term>Darunavir</mesh_term>
	<criteria>Patients HIV infection Inform consent document . To initiated therapy contain DRV / c followup least 24 Weeks . Not evaluable clinical data patient Patients routinely follow center Patient le 18 year age .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>